within Pharmacolibrary.Drugs.ATC.S;

model S01AX09
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00025,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01AX09</td></tr><td>route:</td><td>ophthalmic</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Chlorhexidine is a broad-spectrum antiseptic and disinfectant used primarily for skin disinfection, wound cleaning, and in dental care to reduce oral bacteria. It is not absorbed appreciably when applied topically or as an oral rinse. Ophthalmic preparations (ATC code S01AX09) are intended for use in eye infections or preoperative antisepsis. Chlorhexidine is widely approved for topical and dental use, but ophthalmic use is less common and not universally approved.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for chlorhexidine in adults following ophthalmic or topical administration; parameters primarily inferred from limited absorption and low systemic exposure, since published human PK models following ophthalmic administration are lacking.</p><h4>References</h4><ol><li><p>Xuguang, S, et al., &amp; Xiaotang, Y (2006). Pharmacokinetics of chlorhexidine gluconate 0.02% in the rabbit cornea. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 22(4) 227–230. DOI:<a href=\"https://doi.org/10.1089/jop.2006.22.227\">10.1089/jop.2006.22.227</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16910862/\">https://pubmed.ncbi.nlm.nih.gov/16910862</a></p></li><li><p>Jones, L, &amp; Powell, CH (2013). Uptake and release phenomena in contact lens care by silicone hydrogel lenses. <i>Eye &amp; contact lens</i> 39(1) 29–36. DOI:<a href=\"https://doi.org/10.1097/ICL.0b013e31827d4f25\">10.1097/ICL.0b013e31827d4f25</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23271476/\">https://pubmed.ncbi.nlm.nih.gov/23271476</a></p></li><li><p>Ali, FS, et al., &amp; Garg, SJ (2021). Aqueous Chlorhexidine Compared with Povidone-Iodine as Ocular Antisepsis before Intravitreal Injection: A Randomized Clinical Trial. <i>Ophthalmology. Retina</i> 5(8) 788–796. DOI:<a href=\"https://doi.org/10.1016/j.oret.2020.11.008\">10.1016/j.oret.2020.11.008</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33221515/\">https://pubmed.ncbi.nlm.nih.gov/33221515</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01AX09;
